| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2014 | Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia: a Combined Safety Analysis Profile | Dimkovic, Nada B; Dellanna, Frank; Spasovski, Goce B; Wanner, Christoph; Locatelli, Francesco | Conference Paper | |
| 2014 | Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients | Locatelli, Francesco; Dimković, Nada  ; Spasovski, Goce | Article | |
| 2015 | Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia | Locatelli, Francesco; Spasovski, Goce; Dimković, Nada ; Wanner, Christoph | Article | |
| 2005 | MCI-196, a new phosphate binder, reduces hyperphosphataemia and lipid levels in patients on regular hemodialysis | Locatelli, Francesco; Pontoriero, Giuseppe; Dimković, Nada ; Chambard, A.; Manning, Allan; Nakajima, Shigekazu; Sano, Hiroyuki | Conference Paper | |
| 2015 | Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia | Hertel, Joachim; Locatelli, Francesco; Spasovski, Goce; Dimković, Nada ; Wanner, Christoph | Article | |
| 2014 | The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study | Locatelli, Francesco; Spasovski, Goce B; Dimkovic, Nada B; Wanner, Christoph; Dellanna, Frank; Pontoriero, Giuseppe | Article | |